Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis

Journal of Ultrasound in Medicine

Volumn 33, Issue 11, 2014, Pages 1971-1977

  Qu, En Ze ^a   Zhang, Ying Cai ^a   Li, Zhi Yan ^b   Liu, Yang ^b   Wang, Jin Rui ^c  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b BEIJING 302 HOSPITAL   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Contrast enhanced sonography; Gastrointestinal ultrasound; Noninvasive; Portal hypertension

Indexed keywords

BLOOD PRESSURE; BLOOD VESSELS; LIVER; NONINVASIVE MEDICAL PROCEDURES; ULTRASONIC APPLICATIONS;

CONTRAST-ENHANCED SONOGRAPHIES; CORRELATION COEFFICIENT; HEALTHY INDIVIDUALS; NON-INVASIVE ASSESSMENTS; NONINVASIVE; PORTAL HYPERTENSION; QUANTITATIVE ASSESSMENTS; TIME-INTENSITY CURVES;

ULTRASONOGRAPHY;

CONTRAST AGENT BR1; CONTRAST MEDIUM; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ADULT; BLOOD PRESSURE MEASUREMENT; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; ECHOGRAPHY; FEASIBILITY STUDY; HUMAN; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VENOUS PRESSURE;

ADULT; BLOOD PRESSURE DETERMINATION; CONTRAST MEDIA; FEASIBILITY STUDIES; HUMANS; HYPERTENSION, PORTAL; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY; VENOUS PRESSURE;

EID: 84908673371     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/ultra.33.11.1971     Document Type: Article

References (21)

1. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-354.
2. Halpern EJ Science to practice: noninvasive assessment of portal hypertension - can US aid in the prediction of portal pressure and monitoring of therapy? Radiology 2006; 240: 309-310.
3. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004; 39: 280-282.
4. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993; 188: 405-411.
5. Bolton RP, Mairiang EO, Parkin A, Ware F, Robinson P, Losowsky MS. Dynamic liver scanning in cirrhosis. Nucl Med Commun 1988; 9: 235-247.
6. Cheng MH, Pan ZH, Ling YB, et al. Evaluation of hepatic perfusion and function with modified hepatobiliary scintigraphy. Comput Med Imaging Graph 2009; 33: 182-186.
7. Treiber G, Csepregi A, Malfertheiner P. The pathophysiology of portal hypertension. Dig Dis 2005; 23: 6-10.
8. Richter S, Mücke I, Menger MD, Vollmar B. Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol 2000; 279:G454-G462.
9. Gülberg V, Haag K, Rössle M, Gerbes AL. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 2002; 35: 630-634.
10. Bosch J, Garcia-Pagan JC. Complications of cirrhosis: portal hypertension. J Hepatol 2000; 32: 141-156.
11. Koranda P, Myslivecek M, Erban J, Seidlová V, Husák V. Hepatic perfusion changes in patients with cirrhosis indices of hepatic arterial blood flow. Clin Nucl Med 1999; 24: 507-510.
12. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001; 176: 667-673.
13. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003; 229: 409-414.
14. Berzigotti A, Zappoli P, Magalotti D, Tiani C, Rossi V, Zoli M. Spleen enlargement on follow-up evaluation: a noninvasive predictor of complications of portal hypertension in cirrhosis. Clin Gastroenterol Hepatol 2008; 6: 1129-1134.
15. Vilgrain V, Lebrec D, Menu Y, Scherrer A, Nahum H. Comparison between ultrasonographic signs and the degree of portal hypertension in patients with cirrhosis. Gastrointest Radiol 1990; 15: 218-222.
16. Sacerdoti D, Merkel C, Bolognesi M, Amodio P, Angeli P, Gatta A. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics. Gastroenterology 1995; 108: 1152-1158.
17. Blomley MJ, Lim AK, Harvey CJ, et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study. Gut 2003; 52: 1188-1193.
18. Ridolfi F, Abbattista T, Marini F, et al. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. Dig Liver Dis 2007; 39: 929-935.
19. Zhang CX, Hu J, Hu KW, Zhang C, Wang L, Xu JM. Noninvasive analysis of portal pressure by contrast-enhanced sonography in patients with cirrhosis. J Ultrasound Med 2011; 30: 205-211.
20. Goldberg BB Ultrasound Contrast Agents. London, England: Martin Dunitz Ltd; 1997: 9.
21. Ming-bo Z, En-ze Q, Ji-Bin L, Jin-rui W. Quantitative assessment of hepatic fibrosis by contrast-enhanced ultrasonography. Chin Med Sci J 2011; 26: 208-215.